Page 4 - Provides Update News Today

12.12.2023 - Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) hosted an Investor and Analyst Day in New York City earlier today. CEO Todd Davis and other members of Ligand’s senior management team provided an overview of the company’s business model and ... Seite 1

Bionoid Pharma Inc. Provides Update on Binding Letter of Intent to ...

Your parents – at least mine did – always told you mistakes were there to learn from, be it burnt fingers, electrocution, a bad bet etc. Whatever the mishap or misstep, there was supposedl...

Provides Update on Automotive-First Strategy Significant Reduction in Burn Rate Extending Cash Runway out to 2025DUBLIN, Calif.--(BUSINESS WIRE)--AEye, Inc. (Na

FSD Pharma Inc. (FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions,is pleased to announce that the company, in the upcoming weeks...

/PRNewswire/ -- Dana Incorporated (NYSE: DAN) today announced financial results for the third quarter of 2023....

Lincoln Provides Update on Proposed Acquisition of The Bell Mountain ...

Cordovacann (CSE:CDVA/OTCQB:LVRLF) Provides Update on Star Buds Cannabis ...

The Canadian Securities Administrators CSA announced that the regulatory authorities of each jurisdiction in Canada, except for British Columbia, have adopted Multilateral Instrument 93-101, entitled Derivatives—Business Conduct the Rule. The Rule will come into full force and effect on September 28, 2024. British Columbia is expected to adopt substantially similar rules at a later date, at which time the CSA anticipates Multilateral Instrument 93-101 will be converted to a National Instrument...

01 Communique Provides Update on Business Developments and Third Quarter Fiscal 2023 Results